Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core.
about
Library of diversely substituted 2-(quinolin-4-yl)imidazolines delivers novel non-cytotoxic antitubercular leads.Imidazoline scaffold in medicinal chemistry: a patent review (2012-2015).Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases.Structurally diverse arene-fused ten-membered lactams accessed via hydrolytic imidazoline ring expansion.
P2860
Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core.
@en
Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core.
@nl
type
label
Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core.
@en
Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core.
@nl
prefLabel
Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core.
@en
Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core.
@nl
P2093
P50
P1476
Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core
@en
P2093
Antonis Gavalas
Athina Geronikaki
Bruce Hammock
Christophe Morisseau
Pakornwit Sarnpitak
Sung Hee Hwang
Vladimir Iurchenko
Yan Ivanenkov
P304
P356
10.1016/J.EJMECH.2014.07.023
P577
2014-07-08T00:00:00Z